James Bates (@jamesbatesmd) 's Twitter Profile
James Bates

@jamesbatesmd

Asst Prof RadOnc @WinshipAtEmory #hncsm #lymsm

@UF RadOnc | @UofR MD | @sunygeneseo BS

Minimizing long-term effects of cancer.

Tweets=mine

ID: 1144740006113755137

linkhttps://radiationoncology.emory.edu/people/physicians/bates-james.html calendar_today28-06-2019 22:51:00

1,1K Tweet

1,1K Followers

627 Following

Women in Oncology (@womeninonc) 's Twitter Profile Photo

ASTRO president-elect, Neha Vapiwala, spoke with us for our latest feature where we discussed: šŸ’”Representation and diversity in the field šŸ’”Her top priorities for her term šŸ’”The legacy she hopes to leave Read the full interview at šŸ”—šŸ‘‡ bit.ly/4cnTQ5a

ASTRO (@astro_org) 's Twitter Profile Photo

New in #practicalRO: Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide. #radonc tinyurl.com/barbourpro

New in #practicalRO: Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide. #radonc tinyurl.com/barbourpro
James Bates (@jamesbatesmd) 's Twitter Profile Photo

Wish I could say this was a surprise… (even less of a surprise that a Trump appointee made the ruling) wsj.com/us-news/law/ju…

Pierre Blanchard, MD (@pblanchardmd) 's Twitter Profile Photo

Congrats to my friend Yungan TAO & GORTEC for this huge trial of IO in LA HNSCC Avelumab-cetuximab inferior to cisplatin CRT in fit patients but superior to cetuximab-RT for PFS in cisplatin ineligible population. #ESMO2024

Congrats to my friend <a href="/YG_TAO/">Yungan TAO</a> &amp; GORTEC for this huge trial of IO in LA HNSCC

Avelumab-cetuximab inferior to cisplatin CRT in fit patients but superior to cetuximab-RT for PFS in cisplatin ineligible population. 

#ESMO2024
James Bates (@jamesbatesmd) 's Twitter Profile Photo

An amazing step forward in a relatively challenging to treat disease space that hasn't seen much progress in a long time. Look forward to seeing more results from this!

James Bates (@jamesbatesmd) 's Twitter Profile Photo

Excited to speak about de-escalation in HPV+ oropharyngeal cancer and on late cardiac toxicity all in one meeting SOMERA Sociedad Mexicana de Radioterapeutas - very honored by the invite and the conference venue is truly breathtaking (Huatulco, Oaxaca)

Excited to speak about de-escalation in HPV+ oropharyngeal cancer and on late cardiac toxicity all in one meeting <a href="/somera_mx/">SOMERA Sociedad Mexicana de Radioterapeutas</a> - very honored by the invite and the conference venue is truly breathtaking (Huatulco, Oaxaca)
James Bates (@jamesbatesmd) 's Twitter Profile Photo

Very sad that I could not join in Athens - looks to be an incredible meeting and hope to be in-person at the next iteration!

OncoAlert (@oncoalert) 's Twitter Profile Photo

Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study out on JCO buff.ly/4jeicCV This study investigated the incidence, risk factors, and outcomes of melanoma as a subsequent malignant neoplasm among childhood cancer

Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study out on JCO

buff.ly/4jeicCV 

This study investigated the incidence, risk factors, and outcomes of melanoma as a subsequent malignant neoplasm among childhood cancer